Filing Details

Accession Number:
0001179110-10-015436
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-11-01 19:06:42
Reporting Period:
2010-10-28
Filing Date:
2010-11-01
Accepted Time:
2010-11-01 19:06:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
896264 Usana Health Sciences Inc USNA Medicinal Chemicals & Botanical Products (2833) 870500306
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1261780 H Mark Wilson 3838 West Parkway Blvd
Salt Lake City UT 84120
E.v.p. Of Sales No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-10-28 24,862 $26.06 29,862 No 4 M Direct
Common Stock Disposition 2010-10-28 24,862 $44.79 5,000 No 4 S Direct
Common Stock Acquisiton 2010-10-28 1,159 $40.59 6,159 No 4 M Direct
Common Stock Disposition 2010-10-28 1,159 $44.79 5,000 No 4 S Direct
Common Stock Acquisiton 2010-10-28 3,721 $37.60 8,721 No 4 M Direct
Common Stock Disposition 2010-10-28 3,721 $44.79 5,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Appreciation Rights Disposition 2010-10-28 24,000 $0.00 24,000 $37.60
Common Stock Stock-Settled Stock Appreciation Rights Disposition 2010-10-28 13,200 $0.00 13,200 $40.59
Common Stock Stock-Settled Stock Appreciation Rights Disposition 2010-10-28 60,000 $0.00 60,000 $26.06
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
6,000 2007-04-26 2011-10-24 No 4 M Direct
8,800 2008-04-19 2012-10-19 No 4 M Direct
90,000 2009-07-21 2014-01-21 No 4 M Direct
Footnotes
  1. The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights desclosed in Table II.
  2. Weighted Average Price. Price Range was $44.55 to $44.98.